Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07280650

Feasibility and Acceptability of Earkick for Family Caregivers: Evaluation Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the feasibility and acceptability of using the artificial intelligence (AI) chatbot mobile application (called Earkick) to support the well-being of informal care partners of individuals with traumatic brain injury (TBI), dementia, or Huntington disease (HD). Over an 8-week intervention period, up to 60 care partners will engage with the application (app), spending four weeks focusing on physical health and four weeks focusing on mental health. Participants will complete surveys at the midpoint and end of the intervention period. Participants will also complete a semi-structured interview to discuss participants experience using the Earkick app. The study team hypothesizes that care partners will find the chatbot acceptable and feasible to use in daily life, and that there will be low attrition and high completion rates of the study.

Conditions

Interventions

TypeNameDescription
OTHEREarkick appParticipants will download the app with the study team's help and set it up. The participants will select topics of interest to focus on during the 8-week use of the Earkick app. Participants will choose one mental health related topic to focus on from weeks 1-4 and one physical health related topic to focus on from weeks 5-8. During these 4 week cycles the participants will be guided to engage with the app's "Chat" feature, which offers conversational support through interactions with the chatbot. Additionally, participants will complete surveys at baseline, the midpoint, and end of the 8-week intervention period. Participants will also complete a semi-structured interview to discuss their experience using the Earkick app.

Timeline

Start date
2026-03-01
Primary completion
2027-05-31
Completion
2027-06-30
First posted
2025-12-12
Last updated
2026-02-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07280650. Inclusion in this directory is not an endorsement.